Serial 87748724
Live / Registered — Registered (as of 04 Jan 2022)
What this means for you
Registered since 04 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87748724
- Registration number
- 6608643
- Mark type
- Design / logo
- Filed
- 09 Jan 2018
- Published for opposition
- 11 Sept 2018
- Registered
- 04 Jan 2022
- Attorney of record
- Erica L. Han
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas; development of pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; development of pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases
Owner
- BioCryst Pharmaceuticals, Inc., Durham, NC, US
- BioCryst Pharmaceuticals, Inc., Durham, NC, US
- BioCryst Pharmaceuticals, Inc., Durham, NC, US
Prosecution history
- 03 Dec 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 02 Dec 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 03 May 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 04 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
- 27 Nov 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Nov 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Nov 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Nov 2021 — USE AMENDMENT FILED
- 03 Nov 2021 — TEAS STATEMENT OF USE RECEIVED
- 21 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 May 2021 — SOU EXTENSION 5 GRANTED
- 06 May 2021 — SOU EXTENSION 5 FILED